Does ENCORAFENIB Cause Decreased appetite? 261 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 261 reports of Decreased appetite have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 3.1% of all adverse event reports for ENCORAFENIB.
261
Reports of Decreased appetite with ENCORAFENIB
3.1%
of all ENCORAFENIB reports
32
Deaths
111
Hospitalizations
How Dangerous Is Decreased appetite From ENCORAFENIB?
Of the 261 reports, 32 (12.3%) resulted in death, 111 (42.5%) required hospitalization, and 6 (2.3%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ENCORAFENIB Alternatives Have Lower Decreased appetite Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN